Manager PR & Communications Jan Phillip Denkers
Indivumed: New Publication in Discover Oncology
Indivumed GmbH announced the fourth research publication enabled by the Indivumed Omics Hub. An interface for members of the Indivumed Global Clinical Network, the Omics ...
Read more …New management at altona Diagnostics in Argentina and Brazil
After more than six years at the helm of the Argentine and Brazilian subsidiaries of altona Diagnostics based in Buenos ...
Read more …Deeper Insights in Breast Cancer Metastasis
A collaborative effort between researchers from DESY, the University Medical Center Hamburg-Eppendorf (UKE), ...
Read more …SurgMark: FDA 510(k) Clearance for SchurSign Tissue Marker
In January SurgMark GmbH announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for ...
Read more …Synchron Acquires Equity Stake in ACQUANDAS
Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the acquisition of an equity stake ...
Read more …"Stealth Effect"
An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...
Read more …Evotec announces CEO transition
Evotec SE announced that after close to 15 years of successful service, CEO Dr Werner Lanthaler has informed the company, that he will not continue ...
Read more …European XFEL: New Chairman of the Management Board
Physicist Prof Thomas Feurer has assumed the role of the new Chairman of the European XFEL Management Board on 1 January. Hailing from the University ...
Read more …The LSN year in snapshots
Dear Cluster stakeholders, dear LSN enthusiasts, we have searched through our photo archive and compiled a few highlights in pictures from the Life Science Nord ...
Read more …Cooperation for faster drug discovery
The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...
Read more …Dr. Jürgen Walkenhorst is leaving Life Science Nord
Dr. Jürgen Walkenhorst has been LSN Managing Director since June 1st, 2022 and is leaving the cluster due to family reasons at the end of ...
Read more …Indivumed Hosts Onco AI-Med Annual Board Meeting in Hamburg
Indivumed Therapeutics (“Indivumed”) welcomed members of the Oncology Alliance For Individualized Medicine (“Onco AI-Med”) to its global headquarters in Hamburg, ...
Read more …